EX-5619
- Generic Name
- EX-5619
Study to Evaluate the Safety and Pharmacokinetics of CKD-331
- First Posted Date
- 2022-04-19
- Last Posted Date
- 2023-06-09
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 47
- Registration Number
- NCT05335044
- Locations
- 🇰🇷
H plus Yangji hospital, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath